Berliner Boersenzeitung - US abortion ruling threatens access to arthritis drug

EUR -
AED 4.241201
AFN 76.219915
ALL 93.210974
AMD 421.7986
AOA 1060.156793
ARS 1727.958172
AUD 1.63908
AWG 2.081626
AZN 1.959559
BAM 1.954403
BBD 2.32254
BDT 142.738005
BHD 0.43488
BIF 3440.896583
BMD 1.154855
BND 1.478624
BOB 14.004993
BRL 5.916207
BSD 1.153151
BTN 109.628664
BWP 15.63742
BYN 3.410563
BYR 22635.15384
BZD 2.319233
CAD 1.618125
CDF 2611.126427
CHF 0.932311
CLF 0.026733
CLP 1055.559908
CNY 7.795147
CNH 7.793913
COP 3675.544784
CRC 522.915026
CUC 1.154855
CUP 30.603652
CVE 110.186265
CZK 24.201154
DJF 205.338828
DKK 7.47541
DOP 67.250199
DZD 153.530983
EGP 57.54318
ERN 17.322822
ETB 186.117873
FJD 2.553963
FKP 0.857848
GBP 0.857774
GEL 3.019946
GGP 0.857848
GHS 13.520339
GIP 0.857848
GMD 84.878181
GNF 10128.411837
GTQ 8.795715
GYD 241.227629
HKD 9.058306
HNL 30.907112
HRK 7.534038
HTG 150.767698
HUF 362.223087
IDR 20682.294394
ILS 3.477385
IMP 0.857848
INR 109.932764
IQD 1510.627108
IRR 1587694.361999
ISK 141.792902
JEP 0.857848
JMD 183.243508
JOD 0.818791
JPY 182.181232
KES 149.439303
KGS 100.991685
KHR 4673.518854
KMF 493.12343
KRW 1638.640772
KWD 0.357023
KYD 0.961017
KZT 541.135669
LAK 26067.486096
LBP 103263.512096
LKR 386.906578
LRD 208.141271
LSL 18.917964
LTL 3.409986
LVL 0.69856
LYD 7.339597
MAD 10.74762
MDL 20.03577
MGA 4908.365176
MKD 61.481068
MMK 2424.552772
MNT 4152.673297
MOP 9.316283
MRU 46.240358
MUR 54.209096
MVR 17.842347
MWK 1999.510632
MXN 19.917775
MYR 4.721853
MZN 73.807157
NAD 18.917964
NGN 1572.381111
NIO 42.438205
NOK 11.00856
NPR 175.401109
NZD 1.964222
OMR 0.444037
PAB 1.153176
PEN 3.903611
PGK 5.170149
PHP 70.148769
PKR 320.189388
PLN 4.30117
PYG 6876.93715
QAR 4.215887
RON 5.244777
RSD 117.358631
RUB 93.515578
RWF 1693.938243
SAR 4.333626
SBD 9.317771
SCR 16.99798
SDG 693.483603
SEK 10.953417
SGD 1.479663
SLE 28.408276
SOS 659.009126
SRD 43.501064
STD 23903.162464
STN 24.481764
SVC 10.089834
SZL 18.902002
THB 38.159872
TJS 10.643495
TMT 4.041992
TND 3.383582
TRY 54.964638
TTD 7.82126
TWD 37.289687
TZS 3055.166026
UAH 51.602087
UGX 4300.926733
USD 1.154855
UYU 46.366868
UZS 13708.204675
VES 871.004473
VND 30288.376519
VUV 137.825311
WST 3.151849
XAF 655.468764
XAG 0.018606
XAU 0.000271
XCD 3.121053
XCG 2.078224
XDR 0.815196
XOF 655.474435
XPF 119.331742
YER 273.556256
ZAR 18.867557
ZMK 10395.078432
ZMW 22.01327
ZWL 371.86277
  • CMSC

    -0.0600

    21.73

    -0.28%

  • RYCEF

    0.6000

    21

    +2.86%

  • BCE

    0.0600

    22.06

    +0.27%

  • JRI

    -0.0500

    12.67

    -0.39%

  • CMSD

    0.0200

    22.04

    +0.09%

  • NGG

    -0.1600

    80.26

    -0.2%

  • GSK

    -0.0700

    51.46

    -0.14%

  • RBGPF

    0.0000

    69.74

    0%

  • BCC

    -1.6900

    84.8

    -1.99%

  • RIO

    2.5000

    101.51

    +2.46%

  • RELX

    -0.1900

    36.61

    -0.52%

  • BTI

    0.1500

    59.27

    +0.25%

  • VOD

    -0.3800

    15.31

    -2.48%

  • BP

    -1.2300

    41.21

    -2.98%

  • AZN

    5.8800

    161.5

    +3.64%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

(S.G.Stein--BBZ)